Business · 01/10/2008Updated: 10/17/2026 · 1 min read
FDA Clears 11 Drug Products for Sale, Citing Lack of Safety or Effectiveness Concerns
Summary
The US Food and Drug Administration (FDA) has announced that it will not withdraw approval of 11 drug products, including ATROVENT (Ipatropium Bromide) Inhalation Solution, due to concerns over safety or effectiveness, allowing the products to remain on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →